Home › Aldermeesklierkanker › Pennsylvania › Philadelphia
Aldermeesklierkanker klinische studies in Philadelphia, PA
26 studies voor Aldermeesklierkanker zoeken deelnemers op locaties in en rond Philadelphia (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekruterenFase 3
- Thomas Jefferson University, Philadelphia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruterenFase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
RekruterenObservatieonderzoek
- Research Site, Philadelphia
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 3
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekruterenFase 3
- Investigative Site US008, Philadelphia
- Investigative Site US043, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruterenFase 1/2
- Hospital of the University of Pennsylvania, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Rekruteren
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 2
- Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office, Philadelphia
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RekruterenObservatieonderzoek
- Children's Hospital of Philadelphia, Philadelphia
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekruterenObservatieonderzoek
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- en nog 5
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruterenFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mijl verwijderd
- en nog 1
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Investigative Site #109, Philadelphia
Pancreatic Cancer Early Detection Consortium
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruterenFase 1
- Sidney Kimmel Cancer Center, Philadelphia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekruterenFase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mijl verwijderd
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mijl verwijderd
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruterenFase 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Collection of Circulating Biomarkers in Pancreatic Cancer
RekruterenObservatieonderzoek
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
RekruterenFase 2
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruterenFase 1/2
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- University of Pennsylvania, Philadelphia
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruterenFase 2
- Ohio State University-Telemedicine, Philadelphia
- Ohio State University-Telemedicine, Wilmington · 25 mijl verwijderd
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
RekruterenObservatieonderzoek
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
FTT PET/CT in Pancreatic Neuroendocrine Tumors
RekruterenFase 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekruterenObservatieonderzoek
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruterenFase 3
- University of Pennsylvania, Philadelphia
Aldermeesklierkanker studies in andere steden
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Tampa, FL26 studies
- Durham, NC24 studies
- San Diego, CA24 studies
Andere studies in Philadelphia
- Kanker (alle vormen)59 studies
- Borstkanker56 studies
- Niet-kleincellige longkanker51 studies
- Metastatische kanker46 studies
- Prostaatkanker44 studies
- Colorectale kanker44 studies
- Eierstokkanker44 studies
- Longkanker36 studies
- Acute myeloïde leukemie34 studies
- Hartfalen31 studies
- Endometriumkanker28 studies
- Depressie26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.